Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-034303

Senior VP - CCO sold 14,455 shares at an average $9.05 ($130,840)

  • Senior VP - CCO acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Powell Lynne Senior VP - CCO 2018-11-21 Option exercise +12,000 $3.22 $38,640 14,455 D: show line 1 in the form
Powell Lynne Senior VP - CCO 2018-11-21 Sale −12,000 $9.06 $108,720 2,455 D: show line 2 in the form
Powell Lynne Senior VP - CCO 2018-11-21 Sale −2,455 $9.01 $22,120 0 D: show line 3 in the form
Open-market sales · 14,455 sh · avg $9.05 · $130,840

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Powell Lynne Senior VP - CCO 2018-11-21 Option exercise · Emp. Stock Option (Right to Buy) −12,000 101,427 D: show line 4 in the form
Loading xslF345X03/form4.xml…